The EPA and DHA omega-3 ingredient market is anticipated to witness robust growth over the next decade as consumers and manufacturers increasingly prioritise heart health, cognitive function, and overall wellness. In 2025, the market is valued at approximately USD 5.8 billion, and it is projected to reach USD 12.9 billion by 2035, representing an absolute increase of USD 7.1 billion over the forecast period. This expansion corresponds to a compound annual growth rate (CAGR) of around 8.5% between 2025 and 2035, driven by rising health awareness, ageing populations, demand for preventive nutrition, and expanding applications across food, beverage, and dietary supplement sectors.
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are long-chain omega-3 fatty acids primarily found in marine sources such as fish oil, krill oil, and algae oil. These bioactive nutrients are extensively researched for their role in supporting cardiovascular health, brain development and function, visual health, inflammation management, and maternal nutrition. The increasing inclusion of EPA and DHA omega-3 ingredients in fortified foods, functional beverages, nutraceuticals, and medical nutrition products reflects broad consumer and clinical interest in proactive health management.
Quick Market Snapshot (2025–2035)
Market Value (2025): ~USD 5.8 billion
Market Forecast Value (2035): ~USD 12.9 billion
Forecast CAGR: ~8.5%
Primary Forms: Triglyceride, Ethyl Ester, Phospholipid (Algal)
Key End Uses: Dietary Supplements, Functional Foods & Beverages, Clinical Nutrition
Major Growth Regions: North America, Europe, Asia Pacific
Key Drivers: Growing preventive health trends, rising prevalence of chronic diseases, expanding functional food applications
To Access the Complete Data Tables & in-depth Insights, Request a Discount on this report: https://www.factmr.com/connectus/sample?flag=S&rep_id=4050
Market Overview
EPA and DHA omega-3 ingredients are valued for their scientifically supported health benefits and versatile application potential. Dietary supplements remain the largest end-use segment, with fish oil and algal oil formulations widely consumed in soft gels, capsules, liquids, powders, and personalised nutrition formats. Functional foods and beverages fortified with EPA and DHA — including dairy alternatives, juices, nutrition bars, and cereals — are gaining traction among health-conscious consumers seeking convenient, everyday nutritional support.
Clinical nutrition products targeted at specific populations — such as prenatal and postnatal care, elderly nutrition, and metabolic health — also contribute significantly to demand. In addition, the rise of personalised nutrition and digital health platforms is creating opportunities for tailored omega-3 formulations based on individual health needs and lifestyle goals.
Key Demand Drivers
Rising Health Awareness and Preventive Nutrition
Consumers around the world are placing greater emphasis on preventive health measures, driven by rising incidence of chronic conditions such as cardiovascular diseases, cognitive decline, metabolic disorders, and inflammatory conditions. EPA and DHA omega-3s are well recognised for their potential in supporting heart health, cognitive function, and systemic inflammation moderation, prompting increased consumption of omega-3-enriched products.
Ageing Population and Cognitive Health Focus
Ageing populations in many developed and emerging economies are fuelling demand for nutritional solutions that support healthy ageing. DHA, in particular, is essential for brain and visual development and maintenance, making EPA and DHA formulations attractive for senior nutrition and cognitive support products.
Expansion of Functional Food and Beverage Innovation
Food and beverage manufacturers are incorporating EPA and DHA omega-3s into a wide range of everyday products to meet consumer demand for enhanced nutritional offerings. Fortified beverages, snack bars, dairy and non-dairy alternatives, and breakfast cereals that deliver heart and brain health benefits are helping expand the reach of EPA and DHA beyond traditional supplement categories.
Growth in Clinical Nutrition and Maternal Health
Clinical nutrition specialists and health professionals increasingly recommend EPA and DHA for maternal health, infant development, and recovery nutrition. Pregnancy and early-life nutrition programmes that integrate omega-3 support for foetal brain and eye development are key contributors to market growth, especially in regions with strong healthcare focus on prenatal wellness.
Market Segmentation Insights
By Source Type
Marine Sources: Includes fish oil and krill oil; dominant due to established production and high EPA/DHA concentrations.
Algal and Plant Sources: Growing rapidly as a sustainable, vegan-friendly alternative to marine oils; increasingly used in functional foods and supplements.
By Form
Triglyceride Form: Preferred for higher bioavailability and digestive tolerance.
Ethyl Ester Form: Common in concentrated formulations and clinical products.
Phospholipid Form: Found in krill oil and specialised products with unique absorption properties.
By Application
Dietary Supplements: Largest application segment, including capsules, liquids, and powders.
Functional Foods & Beverages: Fortified products targeting everyday nutrition.
Clinical and Medical Nutrition: Formulations for targeted therapeutic support.
Infant and Prenatal Nutrition: Products designed for early-life and maternal health.
Regional Demand Dynamics
North America
North America holds a significant share of the omega-3 market due to high consumer awareness of preventive health, well-established supplement markets, and strong presence of health-focused product innovations. Cardiovascular health and cognitive support remain key reasons for consumption, supported by proactive healthcare guidance and widespread distribution channels.
Europe
Europe exhibits steady growth supported by stringent quality standards, regulatory frameworks favouring nutritional claims, and widespread functional food adoption. Countries with active ageing populations and preventive nutrition initiatives are key contributors to demand for EPA and DHA omega-3 ingredients.
Asia Pacific
Asia Pacific is anticipated to register robust growth through 2035, fuelled by rapid urbanisation, rising disposable incomes, and increasing health consciousness. Markets such as China, Japan, India, and Southeast Asian countries are witnessing growing demand for supplements, functional foods, and clinical nutrition products enriched with omega-3s.
Competitive Landscape
The EPA and DHA omega-3 ingredient market features a competitive landscape comprised of global nutritional ingredient manufacturers, speciality oil producers, and biotechnology firms focused on sustainable production processes. Strategic efforts are concentrated on expanding production capacity, securing sustainable feedstock supply, and enhancing product purity and bioavailability.
Companies are also innovating with non-marine sources, refining extraction and concentration technologies, and developing synergistic formulations that combine omega-3s with other functional nutrients. Collaborations with food and beverage brands, nutraceutical companies, and healthcare providers are common strategies to broaden market reach and develop tailored solutions for specific consumer needs.
Future Outlook
The EPA and DHA omega-3 ingredient market is expected to maintain strong growth through 2035 as health-focused consumer behaviour, expanding functional food portfolios, and supportive regulatory frameworks align to drive demand. Continued advancements in sustainable production — including algal and plant-based omega-3 sources — will further fuel innovation and accessibility.
As preventive health and nutrition become central to global wellness agendas, EPA and DHA omega-3s are poised to remain key ingredients in personalised nutrition, clinical support programmes, and everyday dietary solutions, shaping the future of health-enhancing foods and supplements worldwide.
Have specific requirements or need assistance on report pricing or have a limited budget? Please contact [email protected]
About Fact.MR:
Fact.MR is a global market research and consulting firm, trusted by Fortune 500 companies and emerging businesses for reliable insights and strategic intelligence. With a presence across the U.S., UK, India, and Dubai, we deliver data-driven research and tailored consulting solutions across 30+ industries and 1,000+ markets. Backed by deep expertise and advanced analytics, Fact.MR helps organizations uncover opportunities, reduce risks, and make informed decisions for sustainable growth
